Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container

   
Google
 
Web NewDrugInformation.com

Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container


Drug - Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Amino Acids; Dextrose; Magnesium Chloride; Potassium Phosphate, Dibasic; Sodium Acetate; Sodium Chloride
Multiple ingredients are in alphabetical order.

Strength - 2.75%;20GM/100ML;51MG/100ML;261MG/100ML;216MG/100ML;112MG/100ML
The potency of the active ingredient(s), Amino Acids; Dextrose; Magnesium Chloride; Potassium Phosphate, Dibasic; Sodium Acetate; Sodium Chloride. May repeat for multiple part products.

Applicant - BAXTER HLTHCARE
The firm name holding legal responsibility for Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020147
The FDA assigned number to Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 23, 1995
The date Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - Baxter Healthcare Corp
The full name of the firm holding legal responsibility for the new application of Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container.

Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container


Aminosyn Ii 4.25% M In Dextrose 10% In Plastic Container 4.25%;5gm/100ml;30mg/100ml;97mg/100ml;120mg/100ml;49.3mg/100ml Injectable; Injection
Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 10% In Plastic Container 2.75%;10gm/100ml;51mg/100ml;261mg/100ml;216mg/100ml;112mg/100ml Injectable; Injection
Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 15% In Plastic Container 2.75%;15gm/100ml;51mg/100ml;261mg/100ml;216mg/100ml;112mg/100ml Injectable; Injection
Travasol 2.75% Sulfite Free W/ Electrolytes In Dextrose 20% In Plastic Container 2.75%;20gm/100ml;51mg/100ml;261mg/100ml;216mg/100ml;112mg/100ml Injectable; Injection
Aminosyn Ii 3.5% W/ Electrolytes In Dextrose 25% In Plastic Container 3.5%;25gm/100ml;51mg/100ml;22.4mg/100ml;261mg/100ml;205mg/100ml Injectable; Injection
Aminosyn Ii 4.25% W/ Electrolytes In Dextrose 25% In Plastic Container 4.25%;25gm/100ml;51mg/100ml;22.4mg/100ml;261mg/100ml;205mg/100ml Injectable; Injection
Aminosyn Ii 3.5% M In Dextrose 5% In Plastic Container 3.5%;5gm/100ml;30mg/100ml;97mg/100ml;120mg/100ml;49.3mg/100ml Injectable; Injection
Aminosyn Ii 3.5% M In Dextrose 5% In Plastic Container 3.5%;5gm/100ml;30mg/100ml;97mg/100ml;120mg/100ml;49.3mg/100ml Injectable; Injection
Aminosyn Ii 3.5% M In Dextrose 5% In Plastic Container 3.5%;5gm/100ml;30mg/100ml;97mg/100ml;120mg/100ml;49.3mg/100ml Injectable; Injection
Aminosyn Ii 4.25% M In Dextrose 10% In Plastic Container 4.25%;10gm/100ml;30mg/100ml;97mg/100ml;120mg/100ml;49.3mg/100ml Injectable; Injection

NewDrugInformation